Insulet
PODD
#1018
Rank
A$29.87 B
Marketcap
$425.89
Share price
3.90%
Change (1 day)
33.98%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Insulet (PODD) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : A$3.04 Billion

According to Insulet's latest financial reports the company's total liabilities are A$3.04 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Insulet - Total liabilities on balance sheet (from 2005 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31A$2.72 B4.43%
2022-12-31A$2.60 B26.68%
2021-12-31A$2.05 B24.71%
2020-12-31A$1.65 B8.32%
2019-12-31A$1.52 B49.82%
2018-12-31A$1.01 B20.65%
2017-12-31A$0.84 B54.45%
2016-12-31A$0.54 B64.96%
2015-12-31A$0.33 B26.94%
2014-12-31A$0.26 B42.35%
2013-12-31A$0.18 B23.68%
2012-12-31A$0.14 B9.56%
2011-12-31A$0.13 B52.54%
2010-12-31A$88.6 M-33%
2009-12-31A$0.13 B16.44%
2008-12-31A$0.11 B158.13%
2007-12-31A$43.99 M-78.17%
2006-12-31A$0.20 B77.96%
2005-12-31A$0.11 B22.38%
2004-12-31A$92.56 M93.22%
2003-12-31A$47.9 M-25.37%
2002-12-31A$64.18 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$3.60 B 18.30%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.15 B-62.25%๐Ÿ‡บ๐Ÿ‡ธ USA
A$6.98 B 129.36%๐Ÿ‡บ๐Ÿ‡ธ USA
A$172.75 B 5,568.92%๐Ÿ‡บ๐Ÿ‡ธ USA
A$54.84 B 1,699.73%๐Ÿ‡บ๐Ÿ‡ธ USA
A$66.02 B 2,066.61%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
A$97.91 B 3,113.08%๐Ÿ‡บ๐Ÿ‡ธ USA